How to Buy Lifecore Biomedical Stock
Lifecore Biomedical Inc
Lifecore Biomedical, Inc. , together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally.
Lifecore Biomedical stock last closed at $6.76, up 6.29% from the previous day, and has increased 5.3% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.63 percentage points. Lifecore Biomedical stock is currently +83.75% from its 52-week low of $3.68, and -15.39% from its 52-week high of $7.99.
There are currently 37.03M shares of LFCR outstanding. The market cap of LFCR is $250.29M. In the last 24 hours, 450,295 LFCR shares were traded.
How to Buy Lifecore Biomedical Stock
Wondering how to invest in Lifecore Biomedical stock? Here's how.
- Figure out where to buy Lifecore Biomedical stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Lifecore Biomedical stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Choose your method of payment and add your details.
- Evaluate Lifecore Biomedical stock: The Lifecore Biomedical ticker symbol is LFCR. Is Lifecore Biomedical stock a good investment? Should you buy shares of LFCR? How do LFCR's underlying business fundamentals look? Do top analysts think Lifecore Biomedical is a good buy? Why has LFCR's stock price moved recently? (Hint: Our stock market research tools can help you decide if LFCR is a good stock to buy).
- Execute your LFCR trade: Decide if you will purchase LFCR shares at the current market price or use a limit order to buy LFCR shares at a given price.
- Monitor your LFCR investment: Create a watchlist to keep tabs on your investment in Lifecore Biomedical stock.
Step 1: Figure out where to buy Lifecore Biomedical stock
You need a brokerage account in order to access the NASDAQ market and buy LFCR shares.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you can buy LFCR stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new trading account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best stock market app for beginners, you can securely and quickly fund your account:
Check out the tutorial below to see the process of depositing funds into your new investment account.
Step 4: Evaluate Lifecore Biomedical stock
Once you have chosen the best place to buy Lifecore Biomedical stock, it's very important to analyze their stock before you invest, so you truly wrap your head around the risk as well as the upside.
Lifecore Biomedical quick stats
LFCR Overview
WallStreetZen was designed to help everyday investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on LFCR's stock page.
Is LFCR stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge LFCR's intrinsic value.
Using relative valuations measures:
- LFCR may be overvalued based on its P/B ratio of 112.29x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.09x
You can do additional valuation analysis on LFCR's stock here.
LFCR Financial Health
Passed Health Checks:
- LFCR has $5.42M in cash and short term investments. This is enough to cover its annual cash burn of $3.87M.
- LFCR has cash burn of 3868000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the LFCR balance sheet.
Failed Health Checks:
- LFCR profit margin has gone down from -16.6% to -37.9% in the past year.
- Total LFCR debt is higher than 5 years ago, relative to shareholder equity.
- There are more long-term liabilities than short-term assets on the LFCR balance sheet.
- LFCR has a relatively high debt to equity ratio of 85.36.
Is LFCR stock a Buy, Hold, or Sell, according to analysts?
Out of 2 Wall Street analysts who monitor LFCR, the consensus analyst rating on Lifecore Biomedical is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Lifecore Biomedical stock forecast page.
LFCR Technical Indicators
LFCR Growth Numbers
Last year, LFCR revenue was $130.31M. In the past 5 year, LFCR's revenue has increased by -25.99% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 7.88%.
Dive into LFCR's earnings and revenue performance here.
Who is buying/selling LFCR?
Over the past year, insiders at LFCR have bought more shares than they have sold.
Paul Josephs, Chief Executive Officer of LFCR, was the latest LFCR insider to buy. They bought $97,580.00 worth of LFCR stock on Jan 8, 2025.
Get more info about who owns LFCR stock here.
Can I get consistent income from LFCR stock?
No, Lifecore Biomedical doesn't provide an income stream by paying out dividends.
What do other traders have to say about LFCR?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your LFCR trade
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually sufficient. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, place a limit order.
Click the Open Trade button and eToro will execute your order.
If you want additional help with investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your LFCR investment
Now that you own some LFCR stock, you'll want to keep up with your new investment.
Make a watchlist to track the latest developments regarding your LFCR stock.
LFCR Feed
How to Buy Stock in Lifecore Biomedical
To summarize, here are the 6 steps to buy stock in Lifecore Biomedical:
- Figure out where to buy Lifecore Biomedical stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Evaluate Lifecore Biomedical stock
- Execute your LFCR trade
- Monitor your LFCR investment
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to monitor your new investment in Lifecore Biomedical, add LFCR to your watchlist below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.